Latest Cellular Medicine Development News

Page 1 of 1

Mesoblast Secures US$125M Credit Line, Slashes Debt Costs and Boosts Flexibility

Mesoblast has refinanced its senior debt with a new US$125 million, five-year credit facility that lowers borrowing costs and preserves key assets, positioning the company for strategic growth.

Ada Torres

30 Dec 2025

Top